What Has Been the Progress and Growth of the Typhoid Antibody Testing Market in Recent Years?
The typhoid antibody testing market has seen considerable growth due to a variety of factors.
• The typhoid antibody testing market has grown strongly in recent years. It will grow from $7.83 billion in 2024 to $8.46 billion in 2025, at a CAGR of 8.2%.
The growth is driven by increased collaboration on developing new testing tools, growth in developing countries, rising competition, cost-effective diagnostic kits, and government support.
How Does the Forecast Look for the Typhoid Antibody Testing Market?
The typhoid antibody testing market is expected to maintain its strong growth trajectory in upcoming years.
• The typhoid antibody testing market is forecasted to grow to $11.44 billion by 2029, with a CAGR of 7.8%.
This growth is driven by the increasing prevalence of typhoid, higher morbidity and mortality rates, travel-related testing, rising healthcare spending, and greater awareness. Trends include advancements in testing technologies, global health initiatives, a focus on preparedness, development of new typhoid antibody tests, and rising healthcare expenditures.
What Are The Leading Drivers Of Growth In The Typhoid Antibody Testing Market?
The typhoid antibody testing market is anticipated to expand due to an increase in waterborne diseases. Such diseases are the result of infectious microbes transmitted via polluted water. The prevalence of these diseases is escalating due to factors like unsanitary conditions, lack of clean drinking water, speedy urbanization, changes in the climate, and agricultural runoff. Typhoid antibody tests are essential in detecting, verifying, and tracking the effectiveness of typhoid fever treatment. They contribute to the identification of carriers, allowing for the implementation of preventative strategies, thus playing a significant role in managing and combating waterborne diseases. For example, the Coalition against Typhoid, a US organization devoted to preventing typhoid and other invasive salmonellosis, reported that from January to August 2022, there were 7,681 typhoid cases in the Philippines, a waterborne disease, showing a 109% surge compared to the same time span the prior year. As a result, the increase in waterborne diseases is fuelling the expansion of the typhoid antibody testing market.
How Are The Segments Defined Within The Global Typhoid Antibody Testing Market?
The typhoid antibody testing market covered in this report is segmented –
1) By Product Type: Rapid Serological Tests, Hem-agglutination And Co-agglutination, Counter Immunoelectrophoresis, Typhidot Test, Widal Test
2) By Paratyphi Type: Paratyphi A, Paratyphi B, Paratyphi C
3) By End-User: Hospitals, Serological Testing Centers, Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Rapid Serological Tests: Lateral Flow Immunoassays (LFIA), Immunochromatographic Tests (ICT), Enzyme-Linked Immunosorbent Assays (ELISA)
2) By Hem-agglutination And Co-agglutination: Hemagglutination Assay, Co-agglutination Assay
3) By Counter Immunoelectrophoresis: Gel-Based Counter Immunoelectrophoresis, Paper-Based Counter Immunoelectrophoresis
4) By Typhidot Test: Typhidot-M (IgM) Test, Typhidot-G (IgG) Test
5) By Widal Test: Tube Widal Test, Slide Widal Test
Pre-Book The Typhoid Antibody Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Typhoid Antibody Testing Market?
Leading typhoid antibody testing market firms are concentrating on the creation of innovative items such as molecular diagnostic examinations to improve typhoid fever detection accuracy and speed. Molecular diagnostic tests offer a high degree of specificity and sensitivity, facilitating precise, quick detection of typhoid fever pathogens like Salmonella Typhi. For instance, an Indian diagnostic reagent development company, Vanguard Diagnostics, introduced the VANSCAN typhoid RT PCR test, a molecular diagnostic test, using its proprietary technology in April 2023. This test is meant to identify typhoid fever using a real-time PCR (RT-PCR) testing method, which is more precise and sensitive than traditional serological tests. The VANSCAN Typhoid RT PCR Test represents a notable leap forward in typhoid diagnostics, setting a new benchmark for early, accurate, and reliable disease detection both in India and worldwide.
Who Are the Key Players In The Typhoid Antibody Testing Market?
Major companies operating in the typhoid antibody testing market are:
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Siemens Healthineers AG
• Becton Dickinson and Company
• Quest Diagnostics Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• Meridian Bioscience Inc.
• Sekisui Diagnostics
• CTK Biotech Inc.
• Creative Diagnostics
• Fortress Diagnostics Ltd.
• CerTest Biotec S.L
• InBios International Inc.
• J. Mitra & Co. Pvt. Ltd
• The Native Antigen Company
• AroCell
• AccuBioTech Co. Ltd
• Vanguard Diagnostics private limited.
• Atlas Medical
• Suburban Diagnostics India Private Limited
• Biorex Diagnostics
• Genebio Healthcare Private Limited
• ICT Diagnostics
What Is The Most Dominant Region In The Typhoid Antibody Testing Market?
Asia-Pacific was the largest region in the typhoid antibody testing market in 2023. The regions covered in the typhoid antibody testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
